Publication | Open Access
[111In]In-CP04 as a novel cholecystokinin-2 receptor ligand with theranostic potential in patients with progressive or metastatic medullary thyroid cancer: final results of a GRAN-T-MTC Phase I clinical trial
21
Citations
22
References
2022
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1